Page last updated: 2024-11-02

phenobarbital and Bacterial Pneumonia

phenobarbital has been researched along with Bacterial Pneumonia in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gold, JA1
Rimal, B1
Nolan, A1
Nelson, LS1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phenobarbital Versus Ativan for Refractory Alcohol Withdrawal Treatment in the Intensive Care Unit[NCT04156464]Phase 4142 participants (Anticipated)Interventional2020-07-06Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for phenobarbital and Bacterial Pneumonia

ArticleYear
A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens.
    Critical care medicine, 2007, Volume: 35, Issue:3

    Topics: Adult; Alcohol Withdrawal Delirium; Cohort Studies; Cross Infection; Diazepam; Dose-Response Relatio

2007